SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001854270-23-000064
Filing Date
2023-05-09
Accepted
2023-05-09 16:08:04
Documents
75
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q snti-20230331.htm   iXBRL 10-Q 1983890
2 KANYA RAJANGAM OFFER LETTER senti-employmentagreementk.htm EX-10.1 78516
3 CERTIFICATION a2023033110qex311.htm EX-31.1 11438
4 CERTIFICATION a2023033110qex312.htm EX-31.2 11487
5 CERTIFICATION a2023033110qex321.htm EX-32.1 5726
6 CERTIFICATION a2023033110qex322.htm EX-32.2 5805
  Complete submission text file 0001854270-23-000064.txt   7684387

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20230331.xsd EX-101.SCH 53328
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snti-20230331_cal.xml EX-101.CAL 65789
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snti-20230331_def.xml EX-101.DEF 277329
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20230331_lab.xml EX-101.LAB 638851
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20230331_pre.xml EX-101.PRE 411635
69 EXTRACTED XBRL INSTANCE DOCUMENT snti-20230331_htm.xml XML 1061922
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40440 | Film No.: 23901996
SIC: 2836 Biological Products, (No Diagnostic Substances)